Accessibility Menu
 
Axonics logo

Axonics

(NASDAQ) AXNX

Current PriceN/A
Market CapN/A
Since IPO (2018)+374%
5 Year+165%
1 Year+24%
1 Month+1%

Axonics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$431.90M

Net Income (TTM)

$5.66M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

AXNX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Axonics

Industry

Healthcare Equipment and Supplies

Employees

797

CEO

Raymond Wayne Cohen

Headquarters

Irvine, CA 92618, US

AXNX Financials

Key Financial Metrics (TTM)

Gross Margin

75%

Operating Margin

-7%

Net Income Margin

-2%

Return on Equity

-1%

Return on Capital

-4%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$274.55M

Operating Income

$26.06M

EBITDA

$7.78M

Operating Cash Flow

$2.02M

Capital Expenditure

$3.55M

Free Cash Flow

$5.57M

Cash & ST Invst.

$344.96M

Total Debt

$27.62M

Axonics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$116.19M

+24.8%

Gross Profit

$89.65M

+29.7%

Gross Margin

77.16%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

797

N/A

Net Income

$21.00K

-100.5%

EBITDA

$421.00K

-93.9%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$312.71M

-8.5%

Accounts Receivable

$62.64M

+28.0%

Inventory

$113.86M

+52.0%

Long Term Debt

$29.90M

+3313.2%

Short Term Debt

$2.61M

-33.8%

Return on Assets

-0.85%

N/A

Return on Invested Capital

-3.87%

N/A

Free Cash Flow

$2.40M

-121.5%

Operating Cash Flow

$922.00K

-92.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ONEM1Life Healthcare, Inc.
$16.47+0.00%
CBAYCymaBay Therapeutics, Inc.
$32.48+0.03%
SWTXSpringWorks Therapeutics, Inc.
$46.99+0.02%
RYZBRayzeBio, Inc. Common Stock
$62.49+0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About AXNX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.